An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers

PLoS ONE

Volumn 12, Issue 12, 2017, Pages

  Airhart, Sophia E ^c   Shireman, Laura M ^b   Risler, Linda J ^b   Anderson, Gail D ^b   Gowda, G A Nagana ^b   Raftery, Daniel ^b   Tian, Rong ^b   Shen, Danny D ^b   O’Brien, Kevin D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; NIAGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE RIBOSIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; URIC ACID; NICOTINAMIDE; NICOTINAMIDE-BETA-RIBOSIDE;

ADULT; ARTICLE; BLOOD CHEMISTRY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG HALF LIFE; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; MALE; MYOSITIS; NORMAL HUMAN; OUTCOME ASSESSMENT; PHARMACOKINETIC ASSAY; STEADY STATE; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; DIETARY SUPPLEMENT; MIDDLE AGED; NEWBORN; ORAL DRUG ADMINISTRATION; YOUNG ADULT;

ADMINISTRATION, ORAL; ADULT; DIETARY SUPPLEMENTS; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INFANT, NEWBORN; MALE; MIDDLE AGED; NAD; NIACINAMIDE; YOUNG ADULT;

EID: 85037345104     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0186459     Document Type: Article

References (23)

1. Kolwicz SC Jr., Purohit S, Tian R. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ Res. 2013; 113(5):603–16. https://doi.org/10.1161/CIRCRESAHA.113.302095 PMID: 23948585
2. Marin-Garcia J, Goldenthal MJ. Mitochondrial centrality in heart failure. Heart Fail Rev. 2008; 13 (2):137–50. https://doi.org/10.1007/s10741-007-9079-1 PMID: 18185992
3. Neubauer S. The failing heart—an engine out of fuel. N Engl J Med. 2007; 356(11):1140–51. https://doi.org/10.1056/NEJMra063052 PMID: 17360992
4. Bayeva M, Gheorghiade M, Ardehali H. Mitochondria as a therapeutic target in heart failure. Journal of the American College of Cardiology. 2013; 61(6):599–610. https://doi.org/10.1016/j.jacc.2012.08.1021 PMID: 23219298
5. Doenst T, Nguyen TD, Abel ED. Cardiac metabolism in heart failure: implications beyond ATP production. Circ Res. 2013; 113(6):709–24. https://doi.org/10.1161/CIRCRESAHA.113.300376 PMID: 23989714
6. Nickel A, Loffler J, Maack C. Myocardial energetics in heart failure. Basic research in cardiology. 2013; 108(4):358. https://doi.org/10.1007/s00395-013-0358-9 PMID: 23740216
7. Wang W, Karamanlidis G, Tian R. Novel targets for mitochondrial medicine. Sci Transl Med. 2016; 8 (326):326rv3. https://doi.org/10.1126/scitranslmed.aac7410 PMID: 26888432
8. Karamanlidis G, Lee CF, Garcia-Menendez L, Kolwicz SC, Suthammarak W, Gong G, et al. Mitochondrial Complex I Deficiency Increases Protein Acetylation and Accelerates Heart Failure. Cell Metabolism. 2013; 18. https://doi.org/10.1016/j.cmet.2013.07.002 PMID: 23931755
9. Lee CF, Garcia-Menendez L, Karamanlidis G, Tian R. Restoration of NADH/NAD ration delays pressure overload-induced cardiac dysfunction via regulation of mitochondrial protein acetylation and permeability transition. Circulation. 2013; 128:A15979 (abstr)
10. Hsu CP, Oka S, Shao D, Hariharan N, Sadoshima J. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ Res. 2009; 105(5):481–91. https://doi.org/10.1161/CIRCRESAHA.109.203703 PMID: 19661458
11. Yamamoto T, Byun J, Zhai P, Ikeda Y, Oka S, Sadoshima J. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion. PLoS One. 2014; 9(6): e98972. https://doi.org/10.1371/journal.pone.0098972 PMID: 24905194
12. Canto C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, Cen Y, et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metabolism. 2012; 15(6):838–47. https://doi.org/10.1016/j.cmet.2012.04.022 PMID: 22682224
13. Team RC. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Internet: https://www.r-project.org/ Vienna, Austria 2015 [https://www.r-project.org/.
14. Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer-Verlag New York; 2009.
15. Creeke PI, Dibari F, Cheung E, van den Briel T, Kyroussis E, Seal AJ. Whole blood NAD and NADP concentrations are not depressed in subjects with clinical pellagra. J Nutr. 2007; 137(9):2013–7. PMID: 17709435
16. Trammell SA, Schmidt MS, Weidemann BJ, Redpath P, Jaksch F, Dellinger RW, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016; 7:12948. https://doi.org/10.1038/ncomms12948 PMID: 27721479
17. Guyton JR, Bays HE. Safety considerations with niacin therapy. Am J Cardiol. 2007; 99(6A):22C–31C. https://doi.org/10.1016/j.amjcard.2006.11.018 PMID: 17368274
18. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129(25 Suppl 2):S1–45. https://doi.org/10.1161/01.cir.0000437738.63853.7a PMID: 24222016
19. Ratajczak J, Joffraud M, Trammell SA, Ras R, Canela N, Boutant M, et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nat Commun. 2016; 7:13103. https://doi.org/10.1038/ncomms13103 PMID: 27725675
20. Yoshino J, Mills KF, Yoon MJ, Imai S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metabolism. 2011; 14(4):528–36. https://doi.org/10.1016/j.cmet.2011.08.014 PMID: 21982712
21. Wielgus-Kutrowska B, Kulikowska E, Wierzchowski J, Bzowska A, Shugar D. Nicotinamide riboside, an unusual, non-typical, substrate of purified purine-nucleoside phosphorylases. Eur J Biochem. 1997; 243(1–2):408–14. PMID: 9030766
22. Gomes AP, Price NL, Ling AJ, Moslehi JJ, Montgomery MK, Rajman L, et al. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell. 2013; 155 (7):1624–38. https://doi.org/10.1016/j.cell.2013.11.037 PMID: 24360282
23. Santidrian AF, Matsuno-Yagi A, Ritland M, Seo BB, LeBoeuf SE, Gay LJ, et al. Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. J Clin Invest. 2013; 123 (3):1068–81. https://doi.org/10.1172/JCI64264 PMID: 23426180